The insertion at Chr8: 122,533,694 was shared among patients with MCD and FSGS, and replication in a cultured podocyte cell line induced ZHX2 downregulation, adding to rapidly accumulating evidence (27) of ZHX2 as an important disease modifier gene in primary glomerular diseases. This evidence concerns the gene ZHX2 and focal segmental glomerulosclerosis.